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i
Abstract
Elevated levels in blood serum (>10µmol/L) of the amino acid homocysteine is
strongly correlated with the incidence of heart failure (HF). We present evidence
that the cyclic thioester, homocysteine thiolactone (HTL), a metabolic product of
homocysteine, irreversibly modifies proteins that regulate the contractile process
in cardiac muscle. Two proteins found in the sarcoplasmic reticulum (SR), the
Ca2+ pump (SERCA2), and the ryanodine receptor (RyR2), are responsible for
controlling the cytosolic Ca2+ concentration and hence the contractile state of the
heart. While both improper Ca2+ handling and elevated homocysteine levels have
been considered bio-markers in HF, a direct connection between the two has not
previously been made. We show that HTL reacts with lysine residues on RyR2,
generating a Nε-homocysteine-protein, which results in carbonyl formation and a
change in the Ca2+ sensitivity of RyR2. This is a new molecular mechanism
linking elevated levels of Homocysteine, improper Ca2+ handling and heart
failure. This work was supported by NIH 1 R41 HL105063-01 to J. Abramson and
R. Strongin.
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Chapter 1: Background
1.1 The Contraction of a Muscle Cell
Vertebrate muscle provides mechanical force upon stimulation and can be
separated into three types: skeletal, cardiac and smooth. In muscle cells,
filaments called myofibrils are surrounded by the sarcoplasmic reticulum (SR), a
net-like membrane that is periodically penetrated by the transverse tubular
system (T-tubules)1 at intervals of approximately 1.2µm in skeletal muscle fibers
and 2.5µm in cardiac ventricles. The initiation of contraction is caused by an
electrical excitation, called an action potential, which travels along the surface
membrane of the muscle cell and down the T-tubules, allowing the action
potential to travel across the surface of the entire muscle fiber rapidly. The time
that it takes skeletal muscle to contract is approximately 2-5ms, whereas cardiac
muscle is slightly slower, taking 20-50ms.

Figure 1: The sarcoplasmic reticulum and transverse tubule system of
striated muscle cells2.
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T-tubules are separated from the terminal cisternae 3 of the SR by
approximately 10nm and the interaction between them is referred to as
excitation-contraction coupling (ECC). In this process, three things must happen:
the detection of the propagation of an action potential along the T-tubules, the
transmission of the information by the Dihydrophridine Receptor (DHPR) to the
Calcium Release Channel (CRC), and the release of calcium from the SR. Figure
2 shows a schematic of the flow of calcium out of the SR through the CRC,
where it binds to Troponin C at micro molar concentrations, causing tropomyosin
to change its shape and move away from its blocking position. This change
uncovers the binding sites on the actin filament for myosin, so that the myosin
and actin filaments slide past each other resulting in contraction of the muscle
fibers. After calcium is released from the SR, the Ca2+-Mg2+-ATPase (Ca2+
pump), a 110kDa protein, pumps the calcium back into the lumen of the SR,
causing the muscle to relax 4.

3

.
Figure 2: Excitation-contraction model5. During the action potential, Ca 2+ enters
into the cell through the voltage-dependent Ca2+ channel (DHPR) resulting in an
increase of cytosolic Ca2+ concentrations to micromolar levels. In human cardiac
myocytes, removal of the excess of Ca2+ out of the cytoplasm is accomplished as
follows; 70% by the Sarco/Endoplasmic Reticulum Ca2+ pump, 28% by the Na+/
Ca2+ exchange protein, and the remaining 2% is accomplished by the
plasmalemmal Ca2+- ATPase and mitochondrial uniporter11.

One of the major differences between cardiac and skeletal muscle is that
ECC in cardiac muscle requires a small amount of Ca2+ to cross the T-tubule,
whereas in skeletal muscle ECC is independent of extracellular calcium 6. The
activation of the CRC by calcium in cardiac muscle proceeds by a mechanism
known as Calcium Induced Calcium Release.7
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1.2 Impact of Abnormal Intracellular Ca2+ Cycling
In cardiac muscle there are additional proteins not found in skeletal muscle.
Since Ca2+ enters the cell through the DHPR to initiate cardiac muscle
contraction, there must be a mechanism for purging Ca2+ from the cell. The Na+/
Ca2+ exchange protein (NCX) moves three Na+ ions into the cell and one Ca2+
ion out of the cell. This is the primary mechanism for maintaining low intracellular
Ca2+ concentrations in spite of the fact that Ca2+ enters the cell on each beat of
the heart.
Problems with intracellular Ca2+ cycling have been associated with heart
failure, ischemic heart disease, and several genetic forms of arrhythmias 8. Heart
failure is characterized by abnormal intracellular Ca 2+ cycling that leads to
progressive deterioration of cardiac function. Associated with heart failure is the
inability of the SR to build up an adequate Ca2+ load required for generating
contraction, due to an increased Ca 2+ leak connected with the Ca2+ release
channel. An abnormal Ca2+ leak from the SR during the relaxation phase of the
heart, when the cytosolic Ca2+ concentrations should be low, have been shown
to cause arrhythmias known as delayed afterdepolarizations (DADs) 9. When
intracellular Ca2+ levels rise the NCX assists in removing the Ca 2+ from the cell,
which results in the influx of sodium and can lead to a depolarization of the
extracellular membrane. This unsynchronized action potential can generate
arrhythmias. CRCs that have a diastolic Ca2+ leak have consequently become a
therapeutic target.

5

1.3 Calcium Release Channel
The calcium release channel is a cation-selective trans-membrane protein that is
thought to be a homotetramer, with each of its subunits having a molecular mass
of about 565kDa. These subunits are arranged in a quatrefoil shape, 22 to 27nm
on each side, with a 2nm hole in the center 10. The plant alkaloid ryanodine binds
to this protein with high affinity and high selectivity when the channel is in its
open state11. Because of this, the channel is commonly referred to as the
ryanodine receptor (RyR). The RyR has three isoforms known as RyR1, RyR2
and RyR3, each encoded by a separate gene. All three isoforms appear in brain
tissue; however, RyR1 is found predominately in skeletal muscle, while RyR2 is
found primarily in cardiac muscle. These three isoforms share a 66-70%
homology in amino acid sequence12.

Figure 3: 3D reconstruction of the calcium release channel protein
(commonly known as the ryanodine receptor) 13

1.4 Modification of Ca2+ Release
Ca2+ has a biphasic role in the regulation of RyR. Low micromolar concentrations
of cytoplasmic Ca2+ stimulate the channel while high concentrations (>1mM)
inhibit the channel14. This bell shaped Ca2+ dependence curve has been
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hypothesized to result from two different binding sites: a high affinity site that
opens the channel and a low affinity site that inhibits release. 15 While a rise in
Ca2+ concentration in the cytosol is the principle factor stimulating the CRC16 in
cardiac muscle, in skeletal muscle, where ECC is independent of extracellular
Ca2+, another mechanism of information transfer must be present. It is generally
believed that there is some type of conformational coupling between the DHPR
and the Ryanodine Receptor in skeletal muscle, but the precise mechanism is
unknown.
There is direct evidence, however, for the existence, location and function
of hyperreactive thiols, which have been reported in both skeletal 17 and cardiac
muscle18. Figure 4 shows a proposed model of the Ca2+ release channel that is
regulated by several classes of sulfhydryl groups existing in close proximity and
able to form mixed disulfides. Oxidation of these hyperreactive sulfhydryl groups
to a disulfide linkage, which opens the channel (S1-S2), is then followed by thioldisulfide exchange (S2-S3) that closes the channel, and finally, reduction of the
disulfide bond by the cellular reduced (redox) environment, which resets the
redox status.
In support of this model, it has been shown that the CRC has a welldefined reduction potential that is sensitive to the cellular environment.19 Channel
activators lower the redox potential, making the value more negative, which
favors the oxidation of thiols and the opening of the channel, while channel
inhibitors increase the redox potential to more positive values, which favors the
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reduction of disulfides and the closure of the channel. During oxidative stress or
ischemia, these hyperreactive thiols could oxidize and alter the Ca 2+ sensitivity of
the CRC, allowing small changes in the calcium concentrations to contribute to
significant activation and release of Ca2+.

Figure 4: Model of the Ca2+ release protein gated by SH oxidation
and reduction of three endogenous SH groups 20
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Glutathione (GSH) is part of an antioxidant system and plays an important
part in maintaining the cellular redox status. Along with antioxidant vitamins and
enzymes it shares the job of scavenging peroxide, singlet oxygen and other free
radicals, and it is the most abundant non-protein thiol source in the muscle cell 21.
The eye lens has the highest GSH concentrations at ~10mM, whereas muscle
has about 1-2mM22. During excessive production of reactive oxygen species
(ROS), GSH donates a pair of electrons to a hydroperoxide, resulting in 2 GSH
being oxidized to 1 glutathione disulfide (GSSG). The GSSG can then be
reduced back to GSH by NADPH, which is catalyzed by glutathione reductase
(GR). When production of the ROS overwhelms the recycling capacity of the GR,
GSSG levels rise, resulting in a decrease of the GSH/GSSG ratio and a more
oxidized environment.
While GSSG by itself is an activator of the channel, and GSH is a known
inhibitor, it has been reported that the ratio of GSH/GSSG rather than the total
GSH or total GSSG concentrations determine the response of the RyR 23. The
typical mammalian cell ratio of [GSH]/[GSSG] in the cytosol is ≥30:1, resulting in
a reduction potential of approximately -230mV24. Trans-membrane redox
potential differences are on the order of 50mV, with the lumen of the SR being
more oxidized than the cytosol30.
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1.5 Homocysteine and Homocysteine Thiolactone
Circulating molecules, commonly referred to as biomarkers, can serve as a
means for diagnostics during the diseased state or can identify the perturbations
that precede the disease. One of these biomarkers, Homocysteine (Hcy), is an
accepted independent risk factor for several pathologies including cardiovascular
disease, osteoporosis, Alzheimer’s disease and renal failure 25,26. First observed
by Kilmer McCully in 196927, Hcy, has been the subject of numerous clinical,
experimental, and epidemiological studies seeking to explain the molecular
mechanisms underlying the link between the rise (a mild case of
hyperhomocysteinemia has a range of concentrations in plasma of 15-50µmol/l28)
in concentration of Hcy and this vast array of diseases.
Over 30 studies have been conducted by different groups including; the
Homocysteine Studies Collaboration group, and the Vitamin Intervention for
Stroke Prevention group, often with conflicting results. As an example of the
conflicting results published, a study performed in 1999 found a 5µmol/l rise in
plasma Homocysteine levels leads to a 19% increase in stroke risk and a 25%
rise in coronary artery disease28. However in 2004, the trial of 3,680 randomized
subjects found no change for risk of coronary events with a reduction of a
baseline plasma Homocysteine level by 2µmol/l. Moreover, homocysteine is a
universal intermediate in methionine metabolism and is formed in all human
organs. In mammals, dietary methionine, an essential amino acid, is the only
source of Hcy. Elevated levels of Hcy can be caused by a variety of factors,
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including genetic defects or nutritional and dietary status such as methionine-rich
diets.29 Although the cytotoxic effects of Hcy excess have been confirmed in
many biological model systems, the underlying mechanisms are unknown, and
whether toxicity is caused by Hcy itself or by a Hcy metabolite, is not entirely
clear.

Figure 5: Metabolic conversions of Homocysteine and the chemical
structures of methionine, Homocysteine, and Hcy-thiolactone.30

The thioester Homocysteine Thiolactone (HTL) is one of many metabolites
of Homocysteine and is generated via an error-editing mechanism of methionine
tRNA synthetase. Due to its ability to create a 5-membered ring, HTL is
remarkably stable (with a half life of ~25 hours31) to hydrolysis at physiological
temperatures and pH. Like all thioesters, HTL absorbs UV light with a maximum
at 240nm and ε ~5000 M-1cm-1 in water, and has an unusually low pKa of 7.1 for
its alpha amino group, which allows it to freely diffuse through cell membranes 32.
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HTL reacts readily with the ε-amine of Lys residues to form isopeptide bonds, as
shown in figure 6.

Figure 6: The reaction of HTL with the ε-amine moiety of
protein lysine residues results in a post-translational
modification known as N-Hcy-protein.

1.6 Chemical Mechanism of Oxidative Damage to Proteins
Two possible mechanisms have been proposed to explain how homocystamides
can lead to oxidative damage and loss in protein function. One hypothesis
postulates free radical and oxidative damage to proteins via reactive oxygen
species (ROS) generation upon disulfide bond formation. The other hypothesis
involves αC amino acid radical formation2. It is widely accepted that a majority of
protein backbone cleavage and related damage occurs via alpha-carbon radicals
of amino acid residues. It has also been shown that cysteinyl residues and
glutathione may aid the formation of alpha-carbon radicals on protein residue33.
The alpha-carbon radical can also go on to create a reactive carbonyl species
(RCS) as depicted in figure 7. In this scheme, homocystamides may serve as
sites of protein-radical initiation followed by kinetically-favored hydrogen atom
transfer (HAT), which should promote carbonyl formation.
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Figure 7: Homocystamides serve as sites of protein
radical initiation and concomitant structural changes.

1.7 Previous studies of carbonyl modification of SR proteins
In 2011 Marks and colleagues published a study that implicated carbonyl
modification of RyR1 to age related loss of muscle mass and force in the ageing
mouse model34. They observed an increase of 4 fold of the amount of carbonyls
found on the RyR1 isolated from 24 month old mice as compared to the younger
3-6 month old mice. They concluded that this oxidative damage plays an
important role in the aging mechanism. Carbonyl formation is irreversible. There
are currently no known enzymes that are capable of breaking RCS adducts after
they are formed on proteins in mammalian cells35.
RCS however, will not react indiscriminately with all available residues and
certain residues have been shown to be more susceptible to carbonylation than
others33. Bidasee and colleagues have studied the formation of RCS in a diabetic
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rat model where the RCS are found in the serum and urine of the animal due to
an increased glucose and fatty acid oxidation, increased degradation of ketotic
products, and increased triose pathway flux36. They have identified via mass
spectrometry and site-directed mutagenesis that in the case of the SERCA2a
Ca2+-pump, the major protein found in the SR, four key residues (Arg 164, Lys
476, Lys 481, and Arg 636) are more susceptible to carbonylation and that the
carbonylation of these residues contributes to the Ca2+-pump activity loss
(decrease in ATPase activity) and diastolic dysfunction37. They hypothesized that
these basic residues, with low pKa values, would be more likely to undergo
carbonylation than residues with a higher pKa values, because a greater fraction
would exist in the deprotonated state at a physiological pH of 7.4, which would
render them more susceptible to modification38. In the same model, Bidasee and
colleagues have simulated the effect that carbonyl adducts could have on RyR2
by site-directed mutagenesis mimicking the simultaneous charge neutralization
and increase in bulk induced by carbonylation that would be expected to occur.
They chose amino acids from fragments that had be improperly digested by
trypsin39, indicating a modification due to streptozotocin (STZ)-induced diabetes
that would mimic carbonyl adduct formation. They found that mutations that
simulated carbonylation at Lys2190 or Lys2887 (lysine to tyrosine or tryptophan)
would enhance the Ca2+ sensitivity of RyR2 and mutations at Arg4462 or
Arg4682 (arginine to tyrosine or tryptophan) likely would reduce the Ca2+
sensitivity of RyR234.
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Chapter 2: Materials and General Methods
2.1 Materials
Tritium-labeled ryanodine ([3H]-ryanodine) was purchased from PerkinElmer Life
& Analytical Sciences, Boston Massachusetts, and stored in the freezer at -18˚C
and shielded from light. Unlabeled ryanodine was purchased from Calbiochem (a
division of Merck KGaA, Darmstadt, Germany). A stock solution was prepared at
10mM in 50% Methanol/deionized distilled nanopure water. Sheep hearts were a
gift from Dr. Kent Thornburg, Heart Research Center, Oregon Health and
Science University, Portland, Oregon.
Ethylene Glycol Tetraacetic Acid (EGTA) was purchased from Research
Organics, Cleveland, Ohio, and prepared in deionized distilled nanopure water,
adjusted to pH 7.0 with the addition of potassium hydroxide (KOH) and stored at
room temperature. CytoScint scintillation fluid was purchased from MP
Biomedicals, Costa Mesa, California. Homocysteine Thiolactone (HTL) was a gift
from Dr. Robert M. Strongin, Department of Chemistry, Portland State University,
Portland, Oregon. HTL stock solution was freshly prepared at ~30µM in buffer
containing 250mM KCl, 15mM NaCl, and 20mM Piperazine-1,4-bis(2ethanesulfonic Acid (PIPES) set to pH 7.4 with KOH unless otherwise noted.
Acrylamide/Bis 37.5:1 premixed powder, Immun-Blot PVDF membrane for
protein blotting, detergent compatible (DC) Protein Assay kit, and dual color
precision plus protein standards were obtained from Bio Rad. Oxyblot™ Protein
Oxidation Detection Kit was purchased from Chemicon/Millipore. Anti-Ryanodine
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Receptor 2 antibody (C3-33) was obtained from GeneTex, and horseradish
peroxidase labeled goat anti-mouse secondary antibody was obtained from
Santa Cruz Biotech. Glutathione in both its oxidized and reduced form was
prepared on ice in ice-cold deionized distilled nanopure water containing 10µM
EGTA at a concentration of 0.5M. Once the pH was adjusted to pH 7.0, aliquots
were frozen in liquid N2. All other chemicals were purchased from Sigma-Aldrich
Corporation, St. Louis.

2.2 Cardiac SR Preparation
Cardiac SR vesicles were isolated from sheep hearts obtained from OHSU
based on the method of Meissner and Henderson.40 Unless otherwise stated, all
procedures were carried out in at 4˚C. Once the heart was removed from the
sheep, it was briefly immersed in ice cold buffer containing 300mM Sucrose,
10mM PIPES, 0.5mM PMSF, 1µg/ml Leupeptin at pH 7.4 with KOH (Cardiac
Buffer A). The atria and other connective and fatty tissue were removed and the
remaining ventricles were minced into small pieces to be blended at high speed
in a waring blender for 20 seconds.
After a 30-second rest period, the solution was blended again on high for
20 seconds. The resultant solution was centrifuged at 9,000 x g in the large
Fiberlite F-14 rotor at 4˚C. The supernatant was then filtered through two layers
of cheesecloth and spun at 44,000 x g for 75 minutes in a type 19 rotor at 4˚C.
The resultant pellet was homogenized in Cardiac Buffer A and spun at 25,000 x g
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for 30 minutes at 4˚C. The resulting SR pellet was homogenized in a buffer
containing 100 mM Sucrose, 5 mM HEPES and adjusted to pH 7.2 with
tris(hydroxymethyl) aminomethane-base (Tris-base). Once protein concentration
was determined, and diluted if needed to approximately 20mg/ml, the crude
cardiac SR aliquots were stored in liquid N2.

2.3 Protein Determination
Large volume, crude protein concentrations of the SR were determined by the
method of Kalckar41. The absorbance peak at 280nm is mainly due to the
presence of tyrosine and tryptophan and the peak at 230nm is mainly due to the
peptide bond of the protein backbone. Using this information, absorption was
measured on an Agilent 8453 UV-Visible photodiode array spectrophotometer at
230nm and 280nm. Data were also collected at 260nm in order to correct for
nucleic acids using equations 1 and 2. The process was repeated twice, and the
average protein concentration was calculated.

[SR]mg/ml = 1.45 x Abs280 – 0.74 x Abs260

(Equation 1)

[SR]mg/ml = 0.185 x Abs230 – 0.748 x Abs260

(Equation 2)

When determining the protein concentrations of small volumes (˂200µl) an
assay kit called, Bio-rad DC (detergent compatible) assay, based on the method
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of Lowry42 was used. Small aliquots of the crude protein, and purchased BSA
protein standard were diluted to a final volume of 100µl. The volume was then
reacted with solutions provided in the kit and incubated on an orbital shaker for
15min. Absorbance at 740nm was then recorded for each sample and a standard
curve equation was calculated.

2.4 Determination of Ca2+ stock solutions
Free Ca2+ in experimental solutions were determined using a Ca2+ ion selective
electrodes that consisting of a liquid ion exchanger embedded in a polyvinyl
chloride (PVC) membrane which has direct contact with a graphite rod43,44.
When the functionalized membrane end is immersed into a solution with free
Ca2+ ions, the Ca2+ ions diffuse into the membrane causing an internal positive
charge within the membrane. At the same time, a negative charge builds up on
the solution side of the membrane (due to the loss of positive Ca 2+ ions) until
eventually, the diffusion pressure and the electrostatic forces are balanced and
the diffusion stops. The resulting difference in charge across the membrane is
the membrane potential and when compared to a reference electrode in the
solution without the functionalized membrane, the membrane potential can be
measured by a high impedance electrical meter with mV capability.
In the case of potentiomeric measurements with ion selective electrodes
where there aren’t any redox reactions occurring, the modified Nernst equation,
shown as Equation 3, can be used.
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𝑅𝑇

𝐸 = 𝐸 ° + ( 𝑧𝐹 ) ln[𝐶𝑎2+ ]

(Equation 3)

Where E is the measured membrane potential, E0 is the sum of the potentials on
the electrode side of the membrane and any other junction potentials in the
𝑅𝑇

system. The ( 𝑧𝐹 ) term includes; R the gas constant (8.31 J/mol*K), T the
temperature (295K), z the species charge (2 for Ca2+), and F the Faraday
constant (96,485 Coulomb/mol). The result of that term including a 2.3 factor for
conversion to base log10, is 0.029 V resulting in the following equation.

𝐸 = 𝐸 ° + 29 ∗ log10[𝐶𝑎2+ ](𝑚𝑉 )

(Equation 4)

Where E is the measured potential in mV. This equation describes a line with a
slope of 29 mV / decade change of [Ca2+]. Each time a new probe is put into use
for the first time after fabrication and conditioning, the response to [Ca2+] is
verified to be linear and with a near Nernstian slope value of 29 mV.

2.5 Equilibrium Ryanodine Binding Assay
The molecule ryanodine binds with nanomolar affinity to a single class of proteins
near the junctional region of the SR 45 under certain conditions. With a few
exceptions, such as silver, CRC activators stimulate ryanodine binding, whereas
compounds that inhibit the CRC inhibit binding. Tritium-labeled ryanodine ([3H]-
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ryanodine) binding assays were carried out at a [3H]ryanodine concentration of
1nM, and 14nM unlabeled ryanodine for skeletal SR, and a [ 3H]ryanodine
concentration of 2nM, and 13nM unlabeled ryanodine for cardiac SR.
SR vesicles (0.5mg/ml) were incubated in a buffer containing 250mM KCl,
15mM NaCl, and 20mM Piperazine-1,4-bis(2-ethanesulfonic Acid (PIPES), set at
pH 7.4 and 37˚ Celsius for at least 3 hours. The binding reaction was quenched
by rapid filtration through Whatman glass fiber filters using a Brandel cell
harvester. Filters were washed twice with approximately 4ml of buffer containing
250mM KCl, 15mM NaCl, 20mM tris-(hydroxymethyl)- aminomethane (TRIS),
and 100µM CaCl2 at pH 7.1 (HCl). These filters were then dried in an oven at
50˚C for two hours, then incubated with agitation in 3ml of CytoScint scintillation
fluid for one hour.
Radioactivity was counted by a Beckman LS 6000 scintillation counter
with an efficiency of approximately 55%. Nonspecific binding was measured in
the presence of 200nM unlabeled ryanodine, and 4mM ethylene glycol tetra
acetic acid (EGTA). Total specific activity was determined by adding an aliquot of
experimental [3H]-ryanodine buffer solution to scintillation fluid and counting the
sample.

2.6 Hill Analysis
Calcium dependent ryanodine binding measurements were fit to the Hill equation
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B  Bmax

[ x]n
k d  [ x]n

(Equation 5)

where Bmax is the maximum binding, [x] is the free Ca2+ concentration determined
with the computer program “Bound and Determined” or measured with a Ca2+
electrode, kd is the dissociation constant of the Ca2+ binding site, and n is the Hill
coefficient. The graphing software SigmaPlot was used to determine the best fit
parameters for the half maximal binding concentration (EC 50), which was
calculated by equation 6.

EC50  k

1
 
n
d

(Equation 6)

2.7 Four Parameter Logistic Curve
The Kd values obtained from the calcium dependent ryanodine binding
measurements as a function of HTL concentration were fit to the four parameter
logistic curve equation.
𝑌 = 𝑚𝑖𝑛 +

𝑚𝑎𝑥 − 𝑚𝑖𝑛
𝑥
1 + (𝐸𝐶 )𝐻𝑖𝑙𝑙𝑠𝑙𝑜𝑝𝑒
50

(Equation 7)

2.8 Redox Potential
To study the effects of channel modulators in more reduced or oxidized
environments, it is possible to mimic the cellular redox status by using various
concentrations of GSH and GSSG determined by the following equation46:

E solution  E   2.3

RT
RT
[GSSG]
(7.0  pH actual )  2.3
log
F
nF
[GSH ]2
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(Equation 8)

where Esolution is the redox potential of the solution, E˚ is the standard potential of
glutathione (-0.24V), pHactual is the pH of the buffer, R is the gas constant (8.31
deg-1 mol-1), T is the absolute temperature (K), n is the number of electrons
transferred (n =2 for glutathione) and F is the Faraday constant (96406 J/V).

2.9 Detection of carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH)
2,4-Dinitrophenylhydrazine (DNPH) can be used to detect the carbonyl
functionality of a ketone or aldehyde functional group in the protein side chains
by derivatization to 2,4-dinitrophenylhydrazone (DNPhydrazone). DNPH does not
react with other carbonyl-containing functional groups such as carboxylic acids,
amides, and esters.

Figure 8: Derivatization of protein carbonyls with DNPH
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All procedures for derivatization of protein carbonyls with DNPH and
subsequent detection using the Oxyblot™ Protein Oxidation Detection Kit
(Millipore) follow the procedure as outlined in the kit brochures with the following
two exceptions. The 10X-DNPH derivatization solution was prepared as 100mM
in 100% trifluoroacetic acid (TFA) and diluted ten times with the addition of 9
volumes of water just prior to use, instead of in 2N hydrochloric acid (HCl)47. The
second exception was the use of a non-commercial neutralization solution, which
was prepared containing 2M TRIS/30% Glycerol (same as in kit).
The protein sample was briefly washed three times with deionized/distilled
water and then was derivatized by adding 1mM DNPH solution. The reaction was
allowed to proceed at room temperature for 20 minutes before an equal volume
of neutralization solution was added to the 1X DNPH solution. Care was taken to
not allow the reaction to proceed for more than 30 minutes to prevent side
reactions other than hydrazone linkages to occur.

2.10 SDS-PAGE
Protein samples were prepared for separation via SDS-PAGE by addition of SDS
solution to sample, resulting in a final concentration of 8% (w/v) SDS. After
vortexing, samples were spun on a table top centrifuge at 14,000 rpm for 5
minutes to spin down any non-solubilized proteins. The resultant supernatant
was split into two fractions. One fraction was used to determine the total protein
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concentration, and the second fraction was loaded on the gel after sample
preparation.
Due to the loss of sensitivity of the DNPH labeling when the protein
sample was boiled before separation by SDS-PAGE, an alternative method of
sample preparation was used. This method consisted of solubilizing the sample
at a final concentration of 8% (w/v) SDS followed by a one hour incubation at
room temperature with 3% (v/v) β-mercaptoethanol. This allowed the RyR2 to
enter the gel during electrophoreses.

RyR2

Lane

1

2

Figure 9: β-mercaptoethanol is required to visualize the Ryanodine Receptor.
The signal in lane 1 shows the antibody labeling of RyR2 from a sample that
underwent the alternative method described with 8% (w/v) SDS followed by a
one hour incubation at room temperature with 3% (v/v) β-mercaptoethanol. In
lane 2 the sample was prepared only with 8% (w/v) SDS. After the sample was
separated on the 3-8% SDS-PAGE, the protein was electrophoretically
transferred to the PVDF membrane at a constant 15V for 16 hours at 5˚C.
Membrane was then blocked for 1 hour with Tris Buffered Saline (TBS)
containing 5% nonfat dry milk at 23°C with agitation. Membranes were then
incubated overnight at 1:7000 with a monoclonal antibody to RyR2 residues.
Washing was performed in TBS containing 0.1% Tween-20, 4 times, each time
for 5 minutes at room temperature. The membrane then was incubated with a
Horse Radish Peroxidase (HRP) conjugated secondary antibody against mouse
(1:10,000) for 1 hour. After washing, the membrane was then incubated with
enhanced chemiluminescence detection reagent, before being imaged.
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After each sample’s total protein was determined, 15µg per condition was
loaded on a Bis-Tris 3-8% gradient gel. In addition to the appropriate
acrylamide/bis acrylamide to water ratio, each separating gel consisted of
400mM Tris, 0.1% SDS, 1mg of ammonium persulfate (APS) and 5mM
Tetramethylethylenediamine (TEMED) at pH 8.8 and was poured with a Hoefer
Scientific Instruments (San Francisco, CA) gradient maker. The stacking gel
consisted of 3% acrylamide/bis acrylamide to water ratio along with 5mM Tris,
0.1% SDS, 1mg of APS and 5mM TEMED at pH 6.8. Along with samples, 8µl of
Precision plus, pre-stained, high molecular weight protein standard (Bio-Rad)
was loaded in one well of each gel. The gel was run at 200V for 50 minutes for
protein separation in an ice bath. Under these conditions the dye front runs off
the gel.

2.11 Western Blot
Pre-wet polyvinylidene difluoride (PVDF) membrane (Bio-Rad) via analytical
grade Methanol, gel, filter paper, and sponges were soaked in Towbin Transfer
Buffer48 (25mM Tris-base, 192mM glycin, 20% Methanol (v/v), 0.025% SDS
(w/v)) for 20 minutes. Protein bands were electrophoretically transferred to the
membrane at a constant 15V for 16 hours using a Tank Blot Transfer Apparatus
(Bio-Rad Laboratories, Hercules, CA) at 5˚C. Once transferred, the membrane
was blocked for 1 hour with a Tris Buffered Saline (TBS) containing 200mM Tris,
500mM NaCl at pH 7.5 and 5% nonfat dry milk at 23°C with agitation.
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Membranes were then incubated overnight at 1:150 with a monoclonal antibody
to 2,4-dinitrophenyl residues (part #90451) that accompanied the OxyBlot Protein
Oxidation Detection Kit purchased from Millipore. A standard membrane washing
was performed in TBS containing 0.1% Tween-20 (TBST), 4 times, each time for
5 minutes at room temperature.
After washing with TBST, the membrane was incubated with the
appropriate Horse Radish Peroxidase (HRP) conjugated secondary antibody
against rabbit (1:300) (part #90452 – OxyBlot Protein Oxidation Detection Kit,
Millipore) for 1 hour. The membrane was then washed again in TBST and
incubated with enhanced chemiluminescence detection reagent, from a
SuperSignal West Pico Luminescent Kit (Thermo Fisher Scientific, Waltham,
MA). HRP catalyses oxidation of luminal with peroxide, which then illuminated
the tagged proteins. The image was captured with a Roper Scientific CCD
camera that was then processed using the Alpha Innotech Fluorchem SP system
(Quansys Biosciences, Logan, UT).

2.12 Re-probing
To establish loading controls and verification of ryanodine receptor band location
and density, each PVDF membrane was re-probed for total RyR2. Before reprobing for RyR2, quenching of the goat, anti-rabbit secondary antibody that was
attached to Rabbit Anti-DNPH antibody was accomplished by incubation of
membranes in TBST with 3% w/v sodium azide (NaN3) for a minimum of 3 hours.
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Sodium azide inhibits HRP activity of secondary antibodies and has been
successfully used to quench the previous antibodies for re-probing with another
antibody49. Membranes were then incubated overnight at a dilution of 1:7,000
with a mouse monoclonal antibody against RyR2 (C3-33, GeneTex), followed by
washing and incubation for one hour at a dilution of 1:10,000 with a HRPconjugated secondary antibody against mouse (Santa Cruz Biotech) for 1 hour.
After washing, the membrane was then incubated with enhanced
chemiluminescence detection reagent and imaged.

2.13 Western Blot Analysis
Using the AlphaEaseFC software, an overlay of the Bio-Rad protein ladder and
image produced from the anti-DNPH antibodies, as shown in figure 10, allowed
for the relative mass and density of major bands that had been carbonylated to
be determined. Once these bands had been identified spot density analysis was
performed by drawing a box around the bands as well as a box used to subtract
out the background as shown in figure 11.
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Figure 10: Determination of the molecular mass of significantly carbonylated
bands. A) Overlay of the image obtained using white reflective light that shows
the Bio-Rad protein ladder (dark red tint) and the image produced from HRP
antibody using the chemiluminescence filter showing carbonylation (dark green
tint). B) Calculations shown include band number which was assigned by the
user, pixel position from the top of the image, user assigned molecular mass in
the Markers window, and software calculated molecular mass in the queries
window, and modified retention value (Rf) where Rf=1 at the bottom of the gel
and Rf=0 at the top of the gel.

Figure 11: Spot density tool in the analysis tab found in the AlphaEaseFC
software.
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The band density when imaged with the anti-DNPH antibodies was then
standardized to the band density when imaged with the anti-RyR2 antibodies.
This was done by dividing the integrated density values that had the background
subtracted from the total carbonylation image, with the integrated density values
that had the background subtracted from the total ryanodine receptor image. This
value, carbonylation per ryanodine receptor, was then normalized to the control
condition before being reported.

2.14 Statistics
Average data is shown as mean ± standard error. Significance of the difference
between control and test values from individual sets of experiments was
calculated by a paired student’s t test.
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Chapter 3: Results
3.1 The Cardiac Ryanodine Receptor is Sensitive to Homocysteine
Thiolactone.
Problems with intracellular Ca2+ cycling have been associated with heart failure,
ischemic heart disease, and several genetic forms of arrhythmias. Our
hypothesis, supported by the following results, is that treatment of SR with HTL
results in carbonyl formation on RyR2 and as a result RyR2 is sensitized to
activation by Ca2+. This is likely to result in spontaneous cardiac arrhythmias and
heart failure. This observation provides the first link between elevated
homocysteine levels in humans and alteration to sarcoplasmic reticulum function.
As shown in Figure 12, and summarized in Figure 13 and Table 1, increasing
levels of Homocysteine Thiolactone decreases the amount of calcium needed for
activation of Ryanodine Binding. At 100nM, a physiologically relevant
concentration, HTL shifts Ca2+ dependent ryanodine binding in cardiac muscle
SR from a kd of 129.7 ± 3.4 to a kd of 102.0 ± 2.7 when the solution redox
potential has been set to -210mV at pH 7.4. This change in Ca2+ dependent
activation was consistently observed in multiple cardiac SR preparations derived
from multiple hearts.
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Figure 12: HTL sensitizes RyR2 to Ca2+ dependent activation. Control cardiac
muscle SR (●); +10nM HTL (●); +50nM HTL (▼); +100nM HTL (▲); +300nM
HTL (■); +500nM HTL (■) Ryanodine binding assay was carried out over a
period of 3 hours at pH 7.4, 37◦C, a redox potential of -210mV and final protein
concentration of 0.5mg/ml. Buffer contained 250mM KCl, 15mM NaCl, and 20mM
PIPES with various EGTA/CaCl2 concentrations calculated to result in various
free Ca2+ values that were later verified with the calcium electrode. The binding
reaction was quenched by rapid filtration through Whatman glass fiber filters
using a Brandel cell harvester. Filters were washed twice with approximately 4ml
of buffer containing 250mM KCl, 15mM NaCl, 20mM TRIS, and 100µM CaCl 2 at
pH 7.1 (HCl). These filters were then dried in an oven at 50˚C for two hours, then
incubated with agitation in 3ml of CytoScint scintillation fluid for one hour.
Radioactivity was counted by a Beckman LS 6000 scintillation counter with an
efficiency of approximately 55%. Data shown as average ± standard error with
n=6. Data was fit using a four parameter Hill curve (equation 5).
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Figure 13: Shift in Ca2+ concentration needed to half maximally activate
ryanodine binding in cardiac muscle as a function of HTL concentration. Data
shown is derived from Figure 12. The data was fit to equation 7, the four
parameter logistic curve resulting in an EC50 of 90.4±15.5nM.

[HTL]
Control
10nM
50nM
100nM
300nM
500nM
Kd Ca2+ 129.7±3. 130.8±4. 130.1±3. 102.0±2. 92.2±3. 89.6±1.
(nM)
4
0
5
7
3
8
Hill
7.0±1.0
4.6±0.7
5.9±0.8
6.0±0.8
7.3±1.5 8.5±1.1
Numbe
r
Table 1: Comparison of Kd Ca2+ values and Hill numbers for different HTL
concentrations.
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3.2 The adduct formed between Homocysteine Thiolactone and excess
Glutathione does not cause functional changes to RyR2.
Previous studies have shown that HTL reacts with a range of free amino acids
and reducing agents31. What is known, comes from kinetic studies that follow
these reaction using UV absorption. These studies were carried out by
monitoring the absorbance of 100µM HTL at 240nm in a 100mM HEPES buffer
at pH 7.4 and 37˚C with each amino acid at a concentration of 1.25mM. It was
reported that the HTL-lysine reaction has a half-life of 3 hours as opposed to 8.5
hours when incubated with Glutathione or the control half-life of 25 hours.
To determine if the large excess of GSH (~2mM) present in our
experiments (and in the cell environment) results in the formation of an HTL-GSH
adduct which then reacts with and causes functional changes to the RyR2, the
following experiment was performed: Two concentrations of HTL, (200nM &
600nM) were incubated at 37˚C, with 4mM GSH in ryanodine binding buffer for
24 hours. A solution of SR and 3H-Ryanodine was then added to both these
solutions, at various free Ca2+ concentrations for an additional 3 hours. As shown
in Figure 14, and summarized in Table 2, there was no change to the
concentration of free Ca2+ needed to half maximally activate ryanodine binding
when GSH is pre-incubated at different concentrations of HTL, and control
conditions in the absence of HTL.

33

1.0

Ryanodine Bound (pmol/mg)

0.8

0.6

0.4

0.2

0.0

-0.2
5e-8

1e-7

2e-7

2e-7

Free Ca2+ (M)
Figure 14: HTL and GSH adducts formed after 24 hours do not change the
sensitivity of RyR2. Control Cardiac SR (●), +100nM HTL (●), +300nM HTL (▼).
4mM GSH and various concentrations of HTL were incubated in ryanodine
binding buffer for twenty four hours before being used in the ryanodine binding
assay that was carried out over a period of 3 hours at pH 7.4, 37 ◦C, and a final
protein concentration of 0.5mg/ml. Data shown as average ± standard error with
n=6. Data was fit using a four parameter Hill curve (equation 5).

[HTL]
Control
100nM
300nM
Kd Ca2+ (nM)
99.8±4.2
104.5±3.7
97.4±3.2
Hill number
6.0±1.2
7.3±0.8
7.9±1.3
2+
Table 2: Comparison of Kd Ca values for different concentrations of HTL.
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3.3 Functional changes on RyR2 by Homocysteine Thiolactone are redox
sensitive.
The effect of 100 nM HTL sensitizing the RyR2 to activation by Ca 2+ was
observed to a greater extent with a reducing solution potential than in an
oxidizing one. At a solution redox potential of -210mV, the Kd of the Ca2+
dependent curve with 100nM HTL is 49.2±4.1nM further to the left than the
control condition. At solution redox potential of -100mV, the Kd of the Ca2+
dependent curve with 100nM HTL is only 36.4±4.6nM further to the left than the
control condition.
Another item of note is that the maximal binding of ryanodine is less at the
-100mV redox solution potential than the -210mV solution redox potential. This is
an artifact due to the high sensitivity of ryanodine binding to salt concentration in
the sample buffer. In order to achieve a solution redox potential of -100mV,
almost half of the total sample volume must be the oxidized glutathione stock
solution. This results in a decrease in the salt concentration and a decrease in
ryanodine binding.
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Figure 15: Solution redox potential alters the ability of HTL to sensitize RyR2 to
Ca2+ dependent activation. Control Cardiac SR set at -100mV (●), +100nM HTL
set at -100mV (●), Control Cardiac SR set at -210mV (▼), +100nM HTL set at 210mV (▲). GSH/GSSG concentrations were incubated with the SR for one hour
before various concentrations of HTL and 3H-Ryanodine were added to start the
ryanodine binding assay that was then carried out over a period of 3 hours at pH
7.4, 37◦C, and a final protein concentration of 0.5mg/ml. Data shown as average
± standard error with n=6. Data was fit using a four parameter Hill curve
(equation 5).
Kd Ca2+
Hill
Total shift
100nM HTL
number
in Kd
(nM)
(nM)
No GSH/ GSSG 133.3±4.3
5.3±0.8
102.4±4.8
5.7±1.3
30.9±6.4
-100mV
140.7±3.8
9.3±1.4
104.3±1.8
7.0±0.6
36.4±4.6
-150mV
136.0±1.7
9.8±1.0
98.5±1.3
8.2±0.7
37.5±4.2
-210mV
139.9±2.5 10.4±1.6
90.7±3.2
9.3±0.9
49.2±4.1
2+
Table 3: Shift in Ca dependent ryanodine binding k d, as a function of redox
potential and HTL concentration
Redox
Potential

Kd Ca2+
(Control)

Hill
number
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3.4 Homocysteine Thiolactone causes a functional change in RyR2 in a time
dependent manner.
As shown in Figure 16, and summarized in Table 4, the longer the incubation
period, the further the HTL can shift the Ca2+ dependent activation curve. With a
2 hour incubation containing 100nM HTL, 0.5mg/ml SR, 3H-Ryanodine at various
free Ca2+ concentrations, the average Kd was only changed by 9.4±11.6nM.
When the HTL and 3H-Ryanodine had been incubated with the SR for 4 hours,
the average Kd was reduced by 25±7.1nM, and with a 6 hour incubation the
average Kd was reduced by 28±5.2nM. However, the error bars on the values
determined from the two hour incubation condition are large. This is possibly due
to ryanodine binding not yet having researched equilibrium after 2 hours of
incubation, and or HTL not yet having completed the reaction with the ryanodine
receptor.
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Figure 16: Shift in Ca2+ dependent ryanodine binding after 6 hours of incubation
with or without 100nM HTL. Control Cardiac SR (●), +100nM HTL (●).The
ryanodine binding assay that was carried out over a period of 6 hours. During the
6 hours, 3H-ryanodine with or without HTL, at pH 7.4, 37◦C, -210mV redox
potential and a final protein concentration of 0.5mg/ml were incubated at various
free Ca2+ concentrations. Data shown as average ± standard error with n=6. Data
was fit using a four parameter Hill curve (equation 5).

2 hours
Kd Ca2+Control
Kd Ca2+100nM
HTL

105.4±8.6

Hill
4 hours
number
4.3±1.0 110.0±5.2

Hill
6 hours
number
4.0±0.7 108.2±3.0

Hill
number
4.8±1.3

95.6±7.9

3.4±1.5 85.3±4.9

5.5±1.5 80.5±4.3

5.9±1.5

Table 4: Shift in Ca2+ dependent ryanodine binding Kd, as a function of time and
HTL concentration.
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3.5 Homocysteine Thiolactone causes carbonylation of RyR2 in a
concentration dependent manner.
Formation of carbonyl functional groups was quantified by addition 2,4dinitrophenylhydrazine (DNPH) to form 2,4-dinitrophenylhydrozone (DNPHhydrazone). Formation of carbonyls on the RyR2 can be followed specifically by
first separating the SR proteins by polyacrylamide gel electrophoresis followed by
Western Blot transfer, and quantified using antibodies to DNPH-hydrazone by
ECL. A representative western blot image showing an increase in carbonyl signal
as a function of HTL is shown in figure 17.
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Figure 17: Western blot image of RyR2 treated with increasing concentrations of
HTL showing increased carbonylation. Protocol is described in the caption to
figure 18.
Lane 1: Control
Lane 2: 10nM HTL
Lane 3: 30nM HTL

Lane 4: 100nM HTL
Lane 5: 200nM HTL
Lane 6: 300nM HTL

Lane 7: 700nM HTL
Lane 8: 1µM HTL
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Each blot was analyzed to determine carbonylation of RyR2. It was then reprobed for total RyR2 for standardization, followed by normalization to the control
condition. This was done by dividing the integrated density values that had the
background subtracted from the total carbonylation image, with the integrated
density values that had the background subtracted from the total ryanodine
receptor image. This value, carbonylation per ryanodine receptor, was then
normalized to the control condition before being collated with multiple trials and
summarized in Figure 18.
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Figure 18: Carbonylation of RyR2 as a function of HTL concentration. RyR2 from
sheep cardiac SR were incubated with various concentrations of HTL for 14-16
hours in a solution at a redox potential of -210mV (2mM GSH & 238µM GSSG),
37˚C and 300nM free Ca2+ (30µM CaCl2 & 35.3µM EGTA) in ryanodine binding
buffer (250mM KCl, 15mM NaCl, 20mM PIPES pH 7.4) before the reaction was
stopped with a series of washes with nano-pure water. Protein was then probed
for carbonylation using 10mM DNPH followed by neutralization (2M TRIS/30%
Glycerol) and solubilized with 8% (w/v) SDS and 3% β-mercaptoethanol. 15µg of
protein per lane were then run on a 3-8% SDS-PAGE gel followed by a 16 hour
transfer onto PVDF membrane at 15V at 4◦C. Monitoring of carbonylation was
done using anti-DNPH residue antibodies (1:150) and standardization was done
using anti-RyR2 antibody (C3-33 at 1:7,000). Three experiments, each with a
different cardiac SR prep, generated 2 PVDF membranes that were imaged and
analyzed and this value, carbonylation per ryanodine receptor, was then
normalized to the control condition before being averaged and reported ±
standard error. The data was fit to equation 7, the four parameter logistic curve
resulting in an EC50 of 108.8±20.3nM.
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3.6 Reducing redox potential enhances Homocysteine Thiolactone
carbonylation on RyR2
We have shown in Figure 15 that at a more negative redox potential, the shift in
the Ca2+ dependence is larger. In Figure 19 we delve into the question of
whether or not carbonylation of the protein is correlated with the redox potential.
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-220mV -220mV -160mV -160mV -100mV -100mV
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Control HTL Control
HTL
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Figure 19: Carbonylation as a function of solution redox potential with or without
100nM HTL. RyR2 from sheep cardiac SR were incubated at various solution
redox potentials with and without 100nM HTL for 14-16 hours at 37 ◦C before the
reaction was stopped with a series of washes. Percent carbonylation was then
determined as described previously. One experiment, generating 4 PVDF
membranes that were imaged and analyzed and this value, carbonylation per
ryanodine receptor, was then normalized to the control condition before being
averaged and reported ± standard error.

Enhancement by HTL (100nM) of carbonylation
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Figure 20: Enhancement of carbonylation by HTL as a function of solution redox
potential. Data shown is derived from Figure 19 by taking the difference
between the average amount of carbonylation with or without HTL. Error is
propagated by taking the square root of the sum of the square error values.
There is no statically significant difference between any of these determination.
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3.7 Carbonylation on RyR2 increases as a function of time, with or without
HTL
As shown in Figure 21, carbonylation increases as a function of time with or
without HTL. This figure also illustrates that either natively or due to sample
handling the Ryanodine Receptor has carbonyl groups present. The reason for
measuring carbonyls before solublization is to measure carbonyl formation in the
native (non-denatured) state. Quantifying the signal was also easier when
measuring carbonyls before solublization due to the high number of carbonyls
exposed after solublization that created a large background signal. While under
the control conditions carbonyl formation appears to reach saturation after four
hours. HTL dependent carbonyl formation appears to increase at 6 hours.
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Figure 21: Carbonylation increases as a function of time and HTL. Sheep cardiac
SR vesicles were incubated with or without 100nM HTL for various amounts of
time in ryanodine binding buffer at a solution redox potential of
-210mV and 37˚C before the reaction was stopped at one time with a series of
washes. One experiment, generating 4 PVDF membranes that were imaged and
analyzed and this value, carbonylation per ryanodine receptor, was then
normalized to the control condition before being averaged and reported ±
standard error.

Enhancement by HTL (100nM) of carbonylation
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Figure 22: Enhancement of carbonylation by HTL as a function of time. Data
shown is derived from Figure 21. The enhancement by 100nM HTL of carbonyl
formation is significant at 4 and 6 hours. (P˂0.1 at 4 hours and P˂0.05 at 6
hours.)
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3.8 Carbonylation on RyR2 increases as a function free Ca2+, with or without
HTL
Carbonylation increases as a function of free Ca2+ concentration with and without
100nM HTL.
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Figure 23: Carbonylation increases as a function of free Ca2+ with (■) or without
(■) 100nM HTL. Sheep cardiac SR vesicles were incubated with or without
100nM HTL at various free Ca2+ concentrations in ryanodine binding buffer at
solution redox potential of -210mV and at 37˚C. The reactions were stopped with
a series of washes after 14 hours. Each value of the HTL condition contains
three experiments, each from three different cardiac SR preparations and
generating 1-3 PVDF membranes each that were imaged, analyzed and this
value, carbonylation per ryanodine receptor, was then normalized to the control
condition before being averaged and reported ± standard error. The condition
without HTL were derived from two experiments, from two different sheep cardiac
SR preparations and both generating 2 PVDF membranes.

Enhancement by HTL (100nM) of carbonylation
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Figure 24: Enhancement of carbonylation by HTL as a function of Ca2+
concentration. Data shown is derived from Figure 21. The enhancement by HTL
of carbonyl formation, as defined in figure 20, is significant at 300nM & 1µM free
Ca2+. (P˂0.05)
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Carbonylation of other proteins as a function of free Ca2+
The Ryanodine Receptor is not the only protein present in the SR prep that
increases carbonylation as a function of free Ca2+ conditions. One such protein
has a molecular mass of 205kDa and is shown in figure 25. It’s carbonylation as
a function of free Ca2+ is quantified in figure 26. This band did not react with an
antibody to Sarcalumenin, a Ca2+ binding protein of molecular mass 170kDa. It is
most likely heavy chain myosin (molecular mass 223kDa). The Kd Ca2+
associated with carbonyl formation of the 205kDa Protein is 77±8nM.
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Figure 25: Western blot image of SR treated with DNPH at increasing
concentrations of free Ca2+ shows increased carbonylation of multiple proteins.
Lane 1: 10nM free Ca2+
Lane 2: 30nM free Ca2+
Lane 3: 50nM free Ca2+

Lane 4: 70nM free Ca2+
Lane 5: 100nM free Ca2+
Lane 6: 300nM free Ca2+

Lane 7: 500nM HTL
Lane 8: 7µM HTL

Carbonylation of the 205kDa Protein
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Figure 26: Carbonylation of the 205kDa protein as a function of free Ca2+
concentration. Sheep cardiac SR was incubated with 100nM HTL at various free
Ca2+ concentrations in ryanodine binding buffer at a solution redox potential of
-210mV at 37˚C for 14 hours. The reaction was stopped with a series of washes.
Two experiment, producing 2-4 PVDF membranes that were imaged and
analyzed and this value, carbonylation per ryanodine receptor, was then
normalized to the control condition before being averaged and reported
± standard error.
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3.9 Standardization of Carbonyl formation
Using a protein ladder that has a known amount of DNPH residues attached to
bovine serum albumin, it was possible to estimate how many carbonyl groups are
formed on the RyR. The oxy-blot kit claims that there are 100 fmols of DNPH
residue in 2.5µl of protein ladder provided. It was found via comparison of the
integrated density values of the ladder and of the RyR2 bands found on three
different PVDF membranes, that 88 fmol of carbonyls were formed above
background. Since there are 15µg of SR loaded on each lane, and using the
reference from a high salt (1M KCl) binding assay (ryanodine receptor is
saturated) carried out on the same SR50, there are 4.8 fmol of RyR2 per µg of
SR, it is possible to calculate that under the following conditions; 1µM free Ca2+, 210mV redox potential, and 500nM HTL, there are ~90 fmol of carbonyl’s are
formed on ~300 fmols of RyR monomers. This works out to be approximately one
in three ryanodine receptors monomers being carbonylated. The active
ryanodine receptor is a tetramer, therefore each tetramer contains ~1.3 carbonyls
under these experimental conditions. At 100nM HTL, this works out to be ~0.43
carbonyl/tetramer or ½ of the receptors are carbonylated.
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Chapter 4: Conclusions & Discussion
In the present study, we show that physiological relevant levels of homocysteine
thiolactone, decreases the amount of free calcium needed for activation of the
Ryanodine Receptor which precedes muscle contraction. This change can cause
defects in function characterized by heart failure, ischemic heart disease, and
several forms of arrhythmias. We propose here that the RyR2’s response to HTL
is caused by the formation of N-Hcy-protein complex which in turn leads to
irreversible carbonyl formation.
This proposal is supported by the similarities in the following experiments.
The similarity between HTL ability to shift Ca2+ dependent ryanodine binding,
IC50=90.4±15.5nM (figure 13) and to induce the formation of carbonyls on RyR2,
EC50=108.8±20.3nM (figure 18) is remarkable. The case for carbonylation being
the underlying mechanism of this functional change is supported by the
functional studies that delved into the question of redox sensitivity (figure 15). It
was observed that there is a greater change from the control condition in a
reduced environment than in an oxidized one. This leads us to speculate that the
RyR2’s response to HTL is potentiated by an interaction with sulfhydryl groups in
a reduced state. This supports our hypothesis that the Nε-Hcy-protein complex
can lead to either formation of a carbonyl or a disulfide. In a reduced environment
the carbonyl formation should be favored. In contrast, measurements of carbonyl
formation, showed no preference for the redox state of the receptor (figure 19 &
figure 20).
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An alternate hypotheses that we have disproven is that the formation of
HTL adduct(s) with the large excess of GSH present in our experiments and in
the cell environment, would form “downstream” products that serve as RyR
modulators (figure 14). Since these studies are done with 700nM HTL or less,
with an excess of 2mM GSH, an argument could be made for the presence of
hyperactive lysine or a preferential condition that pushes the HTL to react with
the RyR2 and not with the other free amine groups available. Since physiological
conditions include a large excess of glutathione and other free amines, and only
a small number of carbonyls are formed on RyR2, there appears to be something
special about the environment that favors carbonyl formation with these hyper
reactive lysines.
The largest discrepancy we have found between the functional change
and the formation of carbonyls is when looking at the time scale over which these
changes happen. Carbonyl formation peaks at 4 hours (figure 21) while the
functional change is still increasing at 6 hours (figure 16 & table 4).
The concentration of free Ca2+ on carbonyl formation had a significant
effect (figure 23). This may be due to Ca2+ acting as a catalyst, or more likely it is
caused by a Ca2+ dependent conformational change in RyR2 which exposes
site(s) at which carbonyls form. This question should be explored further. Further
investigation will also have to be done with respects to the number of receptors
being modified. With approximately one in three ryanodine receptor monomers
being modified in a 14 hour time scale the question is raised whether or not a
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modified ryanodine receptor will exist for enough time to impact heart health in
the body. The ryanodine receptor is usually turned over every 9-12 days51,
however this could happen faster if proteases in the body recognize it functioning
improperly. Is HTL reacting with so few sites on the RyR2 or is the formation
carbonyl groups just an intermediary step and downstream products have not yet
been identified? On a more basic, mechanistic level, future experiments could be
done into how carbonyl formation is altered in the presence of other activators
and inhibitors. These questions can be answered using the protocols outlined
here with the antibodies to DNPH.
Marks and colleagues52 have shown that RyR1 is carbonylated in the
aging mouse model and Bidasee33 has shown that RyR2 is carbonylated in the
diabetic rat model. This is the first time that it has been shown that increasing
HTL concentrations results in the formation of carbonyls on RyR2 and that this
appears to result in a Ca2+ dependent shift in ryanodine binding. This is a new
molecular mechanism linking elevated levels of Homocysteine, improper Ca2+
handling and heart failure.
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